VitMode

Ashwagandha and Cortisol: Does This Adaptogen Really Lower Stress?

"Ashwagandha lowers cortisol" is one of the most repeated claims in the world of adaptogens — and, rarely for this kind of claim, one actually backed by solid numbers from meta-analyses. But the newest, largest meta-analysis to date, from 2025, shows something that changes how this effect should be understood: a drop in blood cortisol and a subjective feeling of reduced stress turn out to be two separate, not always linked, stories.

PZdr Piotr ZielińskiAugust 24, 202612 min read
Table of contents

Why this particular question deserves its own article

In our knowledge-base entry on ashwagandha, we describe it as one of the best-studied adaptogens on the supplement market — backed by dozens of randomized trials covering different populations, doses, and extract forms. But among dozens of potential uses (sleep, libido, muscle strength, cognitive function), one stands out especially often in marketing: cortisol reduction, the stress hormone described in more depth in our cortisol entry. The problem is that "cortisol reduction" and "stress reduction" are treated as near-synonyms in everyday language, while in physiological reality — as the newest literature shows — they aren't necessarily the same phenomenon.

That distinction matters practically for anyone reaching for ashwagandha hoping to feel less stressed. Does a drop in measurable blood cortisol actually translate into a subjective, felt reduction in psychological tension? The answer given by the newest pooled analyses is more nuanced than popular headlines suggest — and that's exactly why it's worth breaking down.

This article assumes basic familiarity with ashwagandha

If you're looking for an introduction to what ashwagandha is, its forms (KSM-66, Sensoril), and its other uses, start with our ashwagandha entry in the knowledge base. Here we focus exclusively on one question: does it really lower cortisol, and by how much, and does that translate into reduced perceived stress.

What the flagship randomized trial showed

The benchmark for most later research on ashwagandha and stress is the work of Chandrasekhar and colleagues from 2012, published in the Indian Journal of Psychological Medicine — one of the first well-designed, double-blind, placebo-controlled trials to assess both biochemical markers and subjective stress scales in the same group of participants.

A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults

Strong evidence

Chandrasekhar K, Kapoor J, Anishetty S · Indian Journal of Psychological Medicine · 2012

The study covered adults with chronic stress, randomly assigned to 60 days of supplementation with a high-concentration ashwagandha root extract (300 mg twice daily) or placebo. The ashwagandha group showed a statistically significant reduction in both subjective stress scales (including the Perceived Stress Scale) and serum cortisol compared with placebo, with no significant adverse effects.

View study

Well-designed, but a single study

Strong evidence

Chandrasekhar's trial is methodologically solid (randomization, blinding, control group) and has been widely cited for over a decade as evidence of ashwagandha's anti-stress effect. But it's still a single study on one specific extract form and one dose — assessing whether the effect repeats across different studies, populations, and extracts requires a pooled analysis of many independent works. Such an analysis didn't appear until over a decade later.

What the largest meta-analysis to date shows

In 2025, Albalawi and colleagues published a systematic review and meta-analysis in Nutrition and Health that, for the first time, separated two distinct kinds of effect in its analysis: the objective drop in cortisol levels and the subjective change in perceived stress, measured with psychometric questionnaires. That separation is crucial, because in many earlier, individual studies both effects were reported together, without clearly distinguishing which one actually reached statistical significance.

Dual impact of Ashwagandha: Significant cortisol reduction but no effects on perceived stress - A systematic review and meta-analysis

Strong evidence

Albalawi AA et al. · Nutrition and Health · 2025

The meta-analysis covered 7 randomized trials assessing cortisol (488 participants) and 6 trials assessing perceived stress. Ashwagandha supplementation was linked to a statistically significant reduction in cortisol of 1.16 µg/dL (95% CI -1.64 to -0.69; p<0.001), with moderate heterogeneity between studies (I²=50.9%). At the same time, no significant effect on perceived stress was observed (SMD=-0.355; 95% CI -1.188 to 0.47; p=0.40).

View study

Two different results within one meta-analysis

Strong evidence

This is a rare situation in supplement literature: one well-designed meta-analysis shows a clearly significant effect on one parameter (cortisol) and no significance on another, related but not identical, parameter (perceived stress). Such a result, though less marketing-friendly than an unqualified "ashwagandha reduces stress," is in fact more scientifically trustworthy — because it shows precisely where the evidence ends and where further research is still needed.

Why lower cortisol doesn't always mean less perceived stress

At first glance, the Albalawi meta-analysis result may seem contradictory — how can the stress hormone drop without a change in the feeling of being stressed? The answer lies in the very nature of cortisol and how the brain processes stress. Cortisol is just one of many mediators of the biological stress response, regulated by the hypothalamic-pituitary-adrenal (HPA) axis, which we describe in detail in our chronic stress entry. Its blood concentration is an objective, measurable biochemical parameter — but perceived stress is a psychological phenomenon, also dependent on cognitive interpretation, life context, sleep quality, and many factors not directly tied to one hormone.

Myth

Since ashwagandha lowers cortisol, anyone who takes it will feel less stressed.

Fact

The 2025 Albalawi meta-analysis shows these two effects diverge — a statistically significant drop in blood cortisol didn't translate into a statistically significant change on perceived stress scales in the pooled analysis of six studies. Possible explanations include insufficient sensitivity of some questionnaires to detect moderate wellbeing changes, short duration in some studies, and the fact that perceived stress depends on far more factors than a single hormone's level.

It's also worth remembering this doesn't mean ashwagandha "doesn't work" on subjective wellbeing — earlier individual studies, like Chandrasekhar's, did show improvement on stress scales. It rather means the effect on perceived stress is less consistent across studies than the effect on cortisol itself, so when many studies are pooled into one meta-analysis, it loses statistical significance even though individual studies showed it. This is exactly the kind of nuance lost in oversimplified headlines like "new study confirms" or "new study debunks."

What this means in practice

Practical takeaways from both studies discussed

  • Ashwagandha's effect on cortisol itself is well confirmed statistically and consistent across studies — this is currently the most solid, hard result available in the literature
  • The effect on subjectively perceived stress is less consistent — some individual studies show it, but the pooled meta-analysis doesn't reach statistical significance
  • Don't expect immediate, guaranteed wellbeing improvement from supplementation alone, without accounting for other factors (sleep, physical activity, load management)
  • Ashwagandha may make sense as part of a broader stress-management strategy, but not as the sole, standalone solution to perceived chronic tension
  • People monitoring cortisol biochemically (e.g., via lab tests) have a more solid basis for expecting a measurable change than people counting solely on improved wellbeing

In practice, this means ashwagandha works best as one piece of a broader puzzle, not as a single solution for perceived stress. Regular physical activity and adequate sleep have more solid, consistent evidence for reducing subjective stress than a single supplement — which we describe in more depth in our chronic stress entry.

Limitations worth keeping in mind

What this data doesn't prove

The Albalawi meta-analysis covered a relatively small number of studies (7 for cortisol, 6 for perceived stress) with moderate heterogeneity between them (I²=50.9% for cortisol) — studies differed in extract form, dose, intervention duration, and population characteristics, which limits confidence in generalizing the result to all preparations and all target groups. The lack of statistical significance for perceived stress also isn't proof that ashwagandha "doesn't work" subjectively — it may reflect an insufficient number of studies in the analysis, too short an observation period, or insufficient sensitivity of the questionnaires used to detect moderate wellbeing changes.

Practical summary

QuestionShort answer
Does ashwagandha lower cortisol?Yes — a drop of 1.16 µg/dL, statistically significant in a meta-analysis of 7 studies
Does the same apply to perceived stress?No significant effect confirmed in the pooled analysis of 6 studies
Did individual studies show improved wellbeing?Yes, e.g. Chandrasekhar's 2012 trial — but the effect isn't consistent across all studies
Is it worth using ashwagandha solely for stress?Better to treat it as part of a broader strategy, not the only solution
What's the quality of the evidence?Strong for cortisol, moderate and inconclusive for perceived stress

Ashwagandha and cortisol in brief

Our editorial recommendation

Ashwagandha remains one of the better-documented adaptogens when it comes to its effect on cortisol — that claim has solid, repeatable support in the literature. But the claim that this automatically translates into reduced perceived stress is currently less well supported than popular supplement marketing suggests.

If you're reaching for ashwagandha hoping for a biochemical effect on cortisol, the evidence is convincing. If you're mainly hoping to feel noticeably less stressed, it's worth treating that as a possible but uncertain additional effect — and not giving up methods with more solidly confirmed effects on subjective wellbeing, such as sleep and regular physical activity.

It's rare to see a meta-analysis draw such a clear line between what the evidence confirms and what remains only a promising hypothesis — and it's that honesty, not a flashy headline, that should shape expectations around ashwagandha.

Dr. Piotr Zieliński, VitMode editorial team

Frequently asked questions

Chandrasekhar's trial used 300 mg of high-concentration extract twice daily for 60 days. However, the studies covered by Albalawi's meta-analysis differed in dosing and duration, so there's no single universal dose confirmed across all studies.

No — the objective drop in cortisol is a real, confirmed biochemical effect. The lack of significance for perceived stress in the pooled analysis means this particular subjective effect is less consistent across studies, not that the supplement has no physiological effect at all.

It shouldn't be treated as a replacement — as we describe in our chronic stress entry, sleep and regular physical activity have more solid, consistent evidence for reducing perceived stress. Ashwagandha can complement these methods, not substitute for them.

The studies covered by the meta-analysis used different extracts and doses, which partly explains the moderate heterogeneity in results (I²=50.9%) — you can't assume an identical effect for every form and dose without referring to the specific study of that particular preparation.

Sources

PZ

dr Piotr Zieliński

Specialist physician in endocrinology, scientific consultant

Piotr reviews content on hormones, metabolic health and supplement pharmacology.

Related articles

Witaminy i suplementy ułożone ze złotą łyżeczką na zielonym tle

Ashwagandha and the Thyroid: Is It Safe with Hashimoto's?

"Ashwagandha is natural, so it can't harm the thyroid" — an assumption worth checking before reaching for this popular adaptogen with Hashimoto's or any other hypothyroidism. A randomized trial in people with subclinical hypothyroidism found that ashwagandha genuinely and significantly raised TSH, T3, and T4 — proof of real biological activity, but also a warning signal for anyone already on thyroid medication.

11 min

August 23, 2026

Zbiór tradycyjnych ziół i przypraw w słoikach i miskach

Adaptogen Ranking: Which One Works Best for Stress, Sleep and Energy

Ashwagandha, rhodiola, ginseng, eleuthero — they're all called 'adaptogens', but they have different mechanisms and different strengths. We sort out which one fits which context, based purely on the strength of the available evidence.

11 min

August 18, 2026

Osoba w spokojnej pozycji medytacyjnej, dłoń spoczywająca na kolanie podczas ćwiczenia oddechowego

HRV Training and Resonance Breathing: Does It Really Reduce Stress?

Your watch shows your HRV, but the measurement itself changes nothing. HRV training (biofeedback) is a specific technique — breathing at a resonance rate, usually around 6 breaths per minute — with real scientific support for reducing stress and anxiety. Here's how it works and how to start.

10 min

August 22, 2026

Lekarz notujący szczegóły podczas konsultacji pacjenta w gabinecie

TRT or Lifestyle Change? What Actually Raises Testosterone Before You Consider Therapy

Before considering testosterone replacement therapy, it's worth checking how much sleep, training, and fat loss can realistically achieve — and when these interventions genuinely aren't enough.

7 min

July 29, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.